About this trial
Postoperative respiratory failure (PORF) remains a critical driver of morbidity, mortality, and incremental care costs in surgical populations. Traditional escalation often involves invasive mechanical ventilation, which is associated with ventilator-associated pneumonia (VAP), prolonged intensive care unit (ICU) stays, and increased resource burden.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age above 18 years
within 48 hours after major surgery
PAO2/FIO2 less than 200
Signs of respiratory distress and respiratory rate (RR) more than 25 cycles/minute
Disqualifiers
Age below 18 years
Pregnant ladies
Orofacial trauma or burns
Active Gastrointestinal bleeding
Trial design
Parallel
Treatments tested in this trial
BIPAP
DeviceThe second arm (NIV group) will be managed by BIPAP device for post-operative respiratory failure
Vapotherm
DeviceThe first arm (HVNC group) will be managed by Vapotherm device for post-operative respiratory failure
Treatment groups
Trial outcomes
Primary outcomes
Weaning success
The primary outcome will be comparing the weaning success (in days) for both arms of the study group. This will be accessed after 48 hours and on a daily basis until the weaning criteria are met or for 28 days.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.